6.74
price up icon0.45%   0.03
 
loading
前日終値:
$6.71
開ける:
$6.62
24時間の取引高:
2.20M
Relative Volume:
1.65
時価総額:
$437.37M
収益:
$65,400
当期純損益:
$-46.34M
株価収益率:
-7.3261
EPS:
-0.92
ネットキャッシュフロー:
$-38.74M
1週間 パフォーマンス:
-38.22%
1か月 パフォーマンス:
-34.24%
6か月 パフォーマンス:
-16.27%
1年 パフォーマンス:
+58.96%
1日の値動き範囲:
Value
$6.31
$6.77
1週間の範囲:
Value
$6.31
$11.16
52週間の値動き範囲:
Value
$3.61
$13.85

CorMedix Inc Stock (CRMD) Company Profile

Name
名前
CorMedix Inc
Name
セクター
Healthcare (1166)
Name
電話
908-517-9500
Name
住所
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Name
職員
14
Name
Twitter
Name
次回の収益日
2025-03-25
Name
最新のSEC提出書
Name
CRMD's Discussions on Twitter

CRMD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CRMD
CorMedix Inc
6.74 437.37M 65,400 -46.34M -38.74M -0.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.69 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
637.36 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
589.15 35.93B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
268.46 34.75B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
267.39 28.24B 3.81B -644.79M -669.77M -6.24

CorMedix Inc Stock (CRMD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-07 開始されました Leerink Partners Outperform
2025-01-13 開始されました D. Boral Capital Buy
2024-08-26 開始されました Rodman & Renshaw Buy
2023-08-10 開始されました RBC Capital Mkts Outperform
2021-02-17 開始されました Needham Buy
2020-09-29 開始されました JMP Securities Mkt Outperform
2020-09-21 開始されました Truist Buy
2019-12-18 開始されました B. Riley FBR Buy
2019-03-26 繰り返されました H.C. Wainwright Buy
2018-12-06 開始されました ROTH Capital Buy
2017-09-25 繰り返されました H.C. Wainwright Buy
2017-08-10 繰り返されました Rodman & Renshaw Buy
2017-05-05 繰り返されました Rodman & Renshaw Buy
2016-11-11 繰り返されました FBR & Co. Outperform
2016-03-17 繰り返されました FBR Capital Outperform
2016-03-03 開始されました FBR Capital Outperform
2015-11-16 繰り返されました ROTH Capital Neutral
2015-10-29 繰り返されました ROTH Capital Neutral
2015-05-06 ダウングレード ROTH Capital Buy → Neutral
2014-12-08 繰り返されました ROTH Capital Buy
2011-10-03 ダウングレード Maxim Group Buy → Hold
すべてを表示

CorMedix Inc (CRMD) 最新ニュース

pulisher
08:06 AM

CorMedix Inc. (NASDAQ:CRMD) Q4 2024 Earnings Call Transcript - Insider Monkey

08:06 AM
pulisher
Mar 28, 2025

CorMedix Inc. Reports Record Q4 Earnings and Growth - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

CorMedix Stock: A Fair-Priced Biotech Company With A Bright Future (NASDAQ:CRMD) - Seeking Alpha

Mar 28, 2025
pulisher
Mar 27, 2025

CORMEDIX ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire

Mar 27, 2025
pulisher
Mar 27, 2025

CORMEDIX ALERT: Bragar Eagel & Squire, P.C. is Investigating CorMedix Inc. on Behalf of ... - Bluefield Daily Telegraph

Mar 27, 2025
pulisher
Mar 27, 2025

Institutions along with individual investors who hold considerable shares inCorMedix Inc. (NASDAQ:CRMD) come under pressure; lose 35% of holdings value - Yahoo Finance

Mar 27, 2025
pulisher
Mar 27, 2025

CorMedix Inc.'s (NASDAQ:CRMD) 35% loss last week hit both individual investors who own 56% as well as institutions - Simply Wall St

Mar 27, 2025
pulisher
Mar 27, 2025

CorMedix targets $50M-$60M revenue for H1 2025 with DefenCath growth - MSN

Mar 27, 2025
pulisher
Mar 26, 2025

Lost Money on CorMedix Inc.(CRMD)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire

Mar 26, 2025
pulisher
Mar 26, 2025

Kirby McInerney LLP Announces Investigation Against CorMedix Inc. (CRMD) on Behalf of Investors - GlobeNewswire

Mar 26, 2025
pulisher
Mar 26, 2025

The Hidden Risks Behind CorMedix's First Profitable Quarter (NASDAQ:CRMD) - Seeking Alpha

Mar 26, 2025
pulisher
Mar 26, 2025

CorMedix Inc (NASDAQ:CRMD) Order Delay - FXDailyReport.com

Mar 26, 2025
pulisher
Mar 26, 2025

Long Term Trading Analysis for (CRMD) - Stock Traders Daily

Mar 26, 2025
pulisher
Mar 26, 2025

INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer & Holzer, LLC - GlobeNewswire

Mar 26, 2025
pulisher
Mar 26, 2025

Cormedix Inc (CRMD) Q4 2024 Earnings Call Highlights: A Profitable Quarter Amidst Strategic ... By GuruFocus - Investing.com Canada

Mar 26, 2025
pulisher
Mar 26, 2025

CorMedix Inc. Achieves Profitability with DefenCath Launch - TipRanks

Mar 26, 2025
pulisher
Mar 25, 2025

CorMedix: Q4 Earnings Snapshot - mySA

Mar 25, 2025
pulisher
Mar 25, 2025

Rodman & Renshaw reiterates CorMedix stock Buy rating, $20 target By Investing.com - Investing.com South Africa

Mar 25, 2025
pulisher
Mar 25, 2025

Rodman & Renshaw reiterates CorMedix stock Buy rating, $20 target - Investing.com

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix (CRMD) Q4 2024 Earnings Call Transcript - Mitrade

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix earnings beat by $0.05, revenue topped estimates - Investing.com Canada

Mar 25, 2025
pulisher
Mar 25, 2025

Needham Cuts CorMedix's Price Target to $12 from $18, Keeps Buy Rating - Marketscreener.com

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix Stock Loses Almost A Third Of Its Market Cap After Downbeat H1 Revenue Outlook – But Retail Shrugs It - Asianet Newsable

Mar 25, 2025
pulisher
Mar 25, 2025

Cormedix: Positive Outlook with Strategic Advancements and Strong Financial Performance - TipRanks

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix Inc. (CRMD) Takes a Hit: What’s Behind the 31% Plunge? - RagingBull

Mar 25, 2025
pulisher
Mar 25, 2025

Nasdaq Gains 50 Points; US New Home Sales Rise In February - Benzinga

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix Stock Loses Almost A Third Of Its Market Cap After Downbeat H1 Revenue Outlook – But Retail Shrugs It Off - MSN

Mar 25, 2025
pulisher
Mar 25, 2025

Earnings call transcript: CorMedix Q4 2024 reports first profit, stock plunges - Investing.com Australia

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix shares tumble after order delay By Investing.com - Investing.com Canada

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix shares tumble after order delay - Investing.com

Mar 25, 2025
pulisher
Mar 25, 2025

Earnings call transcript: CorMedix Q4 2024 reports first profit, stock plunges By Investing.com - Investing.com South Africa

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix Dives on Results - Baystreet.ca

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix Q4 Swings To Profit, Stock Down In Pre-market - Nasdaq

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix Inc. Provides Preliminary Earnings Guidance for the First Half of 2025 - Marketscreener.com

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix (CRMD) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance

Mar 25, 2025
pulisher
Mar 25, 2025

CORMEDIX Earnings Results: $CRMD Reports Quarterly Earnings - Nasdaq

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - Marketscreener.com

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix Hits Major Milestone: First-Ever Profitable Quarter Signals Strong Growth Ahead - StockTitan

Mar 25, 2025
pulisher
Mar 24, 2025

CorMedix Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga

Mar 24, 2025
pulisher
Mar 23, 2025

CORMEDIX Earnings Preview: Recent $CRMD Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 23, 2025
pulisher
Mar 21, 2025

CorMedix Inc expected to post earnings of 14 cents a shareEarnings Preview - TradingView

Mar 21, 2025
pulisher
Mar 19, 2025

CRMD INVESTOR NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages CorMedix Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 20 Deadline in Securities Class Action – CRMD - Business Wire

Mar 19, 2025
pulisher
Mar 18, 2025

CorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025 - The Manila Times

Mar 18, 2025
pulisher
Mar 18, 2025

CorMedix Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

Cormedix Inc. To Report Fourth Quarter And Full Year 2024 Financial Results And Provide A Corporate Update On March 25, 2025 - MENAFN.COM

Mar 18, 2025
pulisher
Mar 16, 2025

(CRMD) Investment Report - Stock Traders Daily

Mar 16, 2025
pulisher
Mar 14, 2025

Li Auto, Xponential Fitness And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga India

Mar 14, 2025
pulisher
Mar 12, 2025

Beeline Holdings Appoints Industry Veteran David Kittle as Special Advisor - The Globe and Mail

Mar 12, 2025
pulisher
Mar 10, 2025

Energy Products and Services Stocks Q4 Recap: Benchmarking MDU Resources (NYSE:MDU) - The Globe and Mail

Mar 10, 2025

CorMedix Inc (CRMD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.99
price up icon 0.39%
$306.97
price down icon 0.34%
$31.37
price down icon 0.88%
$20.32
price down icon 1.36%
$94.95
price down icon 0.47%
biotechnology ONC
$267.39
price up icon 1.82%
大文字化:     |  ボリューム (24 時間):